Key result
Thrombomodulin alfa pharmacokinetic modeling in DIC yields a ~0.95 correlation between actual and predicted concentrations.
Why the study?
The pharmacokinetics of thrombomodulin alfa in patients with disseminated intravascular coagulation and the influence of covariates were not fully elucidated.
How do covariates affect the population pharmacokinetics of thrombomodulin alfa in patients with disseminated intravascular coagulation?
How do covariates affect the population pharmacokinetics of thrombomodulin alfa in patients with disseminated intravascular coagulation?
Answers are grounded in this paper and cite their sources.
Thrombomodulin alfa dosing should be adjusted for body weight, but does not require adjustment for age or hematocrit in patients with DIC.
Thrombomodulin alfa is the recombinant extracellular domain of human thrombomodulin, which shows anticoagulation activity. To elucidate the pharmacokinetics of thrombomodulin alfa in patients with disseminated intravascular coagulation (DIC), population pharmacokinetic (PPK) analysis was performed using plasma concentration data obtained in phase 1 (20 patients, 348 time points) and phase 2 (116 patients, 305 time points) clinical trials. The actual and predicted plasma concentrations of thrombomodulin alfa based on the final PPK model showed a good linear correlation (R = 0.9504), and the pharmacokinetics of thrombomodulin alfa in DIC patients were affected by body weight, age, renal dysfunction, and hematocrit value. The distribution volume and clearance (CL) were proportional to body weight and were significantly increased in patients with lower hematocrit value (male <40%, female <35%). Furthermore, CL was decreased in patients with renal dysfunction and in elderly patients. Based on these results, the standard dose of thrombomodulin alfa is adjusted according to body weight. However, further dose adjustment is not needed based on age and hematocrit value, since these factors did not cause the large changes in plasma concentration that can affect the efficacy or safety.
No takes yet. Share an insight, caveat, or question.
Tsuruta et al. (2010) studied Disseminated Intravascular Coagulation (DIC) (n=136). Thrombomodulin alfa was evaluated on Correlation between actual and predicted plasma concentrations (R = 0.9504).
Synapse has enriched 10 related papers. Consider them for comparative context: